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Recombinant protein production is a useful technology for therapeutic and diagnostic 
applications, namely for polyclonal antibody production. Antibodies are usually raised against 
a specific protein by immunization of animals with the purified protein. The bacterium 
Escherichia coli has been widely used for the bio-production of proteins, but it still presents 
some drawbacks: many proteins of biomedical interest are difficult to express properly in this 
host system, resulting in insoluble protein aggregates. Gene fusion technology has been 
applied to optimize recombinant protein production in E. coli. Fusion partners have also been 
used to potentially increase protein immunogenicity.  
A novel fusion system (Fh8 and H tags) was recently discovered and demonstrated to 
improve antigen production in E. coli [1], presenting also attractive features for the 
development of antibodies. In this work we explored the immunopotentiating properties of H 
tag using a 12 kDa surface adhesion protein of Cryptosporidium parvum (CP12) [2] as model 
antigen. Production yields of Fh8CP12, HCP12 and CP12 recombinant proteins were 
evaluated and polyclonal antibodies were raised against both CP12 and HCP12 antigens. 
Results obtained here demonstrated that the fusion of both Fh8 and H tags to CP12 
improved its expression in comparison with non-fused CP12 protein, and that H tag efficiently 
increased CP12 specific immunogenicity without being removed from the fusion antigen and 
without co-administration of adjuvants, resulting in a more effective and earlier immune 
response. 
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